Paper ยท 33096023
Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells.
Kuenzi BM and 7 others. Cancer Cell, 2020. Cited by 349 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells. Papers, record 33096023. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33096023
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Computational Biology | Major topic |
| Neoplasms | Major topic |
| Cell Line, Tumor | |
| Databases, Factual | |
| Deep Learning | |
| Drug Screening Assays, Antitumor | |
| Drug Synergism | |
| Genotype | |
| Humans | |
| Patient-Specific Modeling |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R50 CA243885 | NCI NIH HHS | United States | R50CA243885 | PubMed and NIH | NIH RePORTER |
| P41 GM103504 | NIGMS NIH HHS | United States | P41GM103504 | PubMed and NIH | NIH RePORTER |
| R01 ES014811 | NIEHS NIH HHS | United States | R01ES014811 | PubMed and NIH | NIH RePORTER |
| F99 CA212456 | NCI NIH HHS | United States | F99CA212456 | PubMed and NIH | NIH RePORTER |
| P30 CA023100 | NCI NIH HHS | United States | P30CA023100 | PubMed and NIH | NIH RePORTER |
| K00 CA212456 | NCI NIH HHS | United States | F99CA212456 | PubMed and NIH | NIH RePORTER |
| U54 CA209891 | NCI NIH HHS | United States | U54CA209891 | PubMed and NIH | NIH RePORTER |
| K00CA212456 | NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 33,096,022 | Biologically Informed Neural Networks Predict Drug Responses. | https://conductscience.org/library/papers/33096022 | PubMed |
| Comment in | 33,239,267 | Artificial Intelligence Predicts Drug Response. | https://conductscience.org/library/papers/33239267 | PubMed |
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,282,027 | Comparison and evaluation of pathway-level aggregation methods of gene expression data. | BMC Genomics | 2012 | https://conductscience.org/library/papers/23282027 | PubMed |
| 2 | 30,770,740 | EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30770740 | PubMed |
| 3 | 26,700,849 | A chemical-genetic interaction map of small molecules using high-throughput imaging in cancer cells. | Mol Syst Biol | 2015 | https://conductscience.org/library/papers/26700849 | PubMed |
| 4 | 25,867,045 | Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B. | Nat Chem Biol | 2015 | https://conductscience.org/library/papers/25867045 | PubMed |
| 5 | 30,679,640 | Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia. | Sci Rep | 2019 | https://conductscience.org/library/papers/30679640 | PubMed |
| 6 | 25,517,437 | Prediction of antibiotic resistance by gene expression profiles. | Nat Commun | 2014 | https://conductscience.org/library/papers/25517437 | PubMed |
| 7 | 30,188,539 | Deep learning in biomedicine. | Nat Biotechnol | 2018 | https://conductscience.org/library/papers/30188539 | PubMed |
| 8 | 29,236,940 | Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer. | Ann Oncol | 2018 | https://conductscience.org/library/papers/29236940 | PubMed |
| 9 | 28,639,053 | Managing the genomic revolution in cancer diagnostics. | Virchows Arch | 2017 | https://conductscience.org/library/papers/28639053 | PubMed |
| 10 | 30,943,338 | Machine Learning in Medicine. | N Engl J Med | 2019 | https://conductscience.org/library/papers/30943338 | PubMed |
1 to 10 of 78
See all 78 referencesCited by264
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 349 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,974,497 | Hepatobiliary cancers digital twins: Integrating artificial intelligence-driven multi-omics with organoid dynamics. | J Transl Int Med | 2026 | https://conductscience.org/library/papers/42974497 | PubMed |
| 42,938,347 | Integration of Multi-Omics in AI-Based Models for Predictive Oncology. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42938347 | PubMed |
| 42,936,269 | xNNPCD identifies regulators of programmed cell death by integrating perturbation transcriptomes with cancer dependency profiles. | NAR Cancer | 2026 | https://conductscience.org/library/papers/42936269 | PubMed |
| 42,921,250 | Estimating Individualized Survival Benefit of Consolidative Metastasis-Directed Radiotherapy Following Chemoimmunotherapy in Nasopharyngeal Carcinoma With Exclusive Distant Metastasis. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42921250 | PubMed |
| 42,868,205 | Interpretable neural networks prioritize cancer driver genes from genome-wide dependency landscapes. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42868205 | PubMed |
| 42,850,682 | Mechanism-Informed Language Modeling and Oxygenated 3D Screening Identify Berberine-Enzalutamide Synergy in Prostate Cancer Models. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42850682 | PubMed |
| 42,823,735 | Artificial intelligence in oncology: linking biological discovery to clinical utility. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42823735 | PubMed |
| 42,781,244 | Leveraging uncertainty estimates for drug response prediction in cancer cell lines. | Bioinform Adv | 2026 | https://conductscience.org/library/papers/42781244 | PubMed |
| 42,778,845 | DiM2-DRP: Dual-Input Multi-View Dynamic Contrastive Learning Framework for Drug Response Prediction. | Interdiscip Sci | 2026 | https://conductscience.org/library/papers/42778845 | PubMed |
| 42,756,558 | Integrating artificial intelligence across the cancer drug discovery pipeline using a design-test-refine workflow. | Front Oncol | 2026 | https://conductscience.org/library/papers/42756558 | PubMed |
1 to 10 of 264
See all 264 cited byGenes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AAVS1 | 17 | PubTator's text mining | https://conductscience.org/library/genes/17 | NCBI Gene |
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| APC | 324 | PubTator's text mining | https://conductscience.org/library/genes/324 | NCBI Gene |
| BCR | 613 | PubTator's text mining | https://conductscience.org/library/genes/613 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| DNER | 92,737 | PubTator's text mining | https://conductscience.org/library/genes/92737 | NCBI Gene |
| DUSP1 | 1,843 | PubTator's text mining | https://conductscience.org/library/genes/1843 | NCBI Gene |
1 to 10 of 35
See all 35 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33096023
GET https://conductscience.org/api/papers/v1/33096023/references?page=2